Cardio-oncology requires a disciplined blend of prevention, surveillance, and multidisciplinary care to preserve oncological intent while mitigating the cardiovascular toxicity of cancer therapies.
Radia et al. (Mon,) conducted a editorial in Cancer and Cardiovascular Disease (Cardio-Oncology). Cardioprotection and surveillance strategies was evaluated. Cardio-oncology requires a disciplined blend of prevention, surveillance, and multidisciplinary care to preserve oncological intent while mitigating the cardiovascular toxicity of cancer therapies.